A Regulatory Element in the Intrinsically Disordered C-Terminal Region of LMTK3 Modulates Its Kinase Domain Interactions and Breast Cancer Phenotypes
Authors:
- Andrea Lauer BetránABAndrea Lauer Betrán
- Alessandro AgnarelliAAAlessandro Agnarelli
- Mark SamuelsMSMark Samuels
- Viviana VellaVVViviana Vella
- Reza Shirazi NiaRNReza Shirazi Nia
- Daniel De VegaDVDaniel De Vega
- Niloufar PoudineNPNiloufar Poudine
- Daniela Carter-LopezDCDaniela Carter-Lopez
- Angeliki DitsiouADAngeliki Ditsiou
- Murat EravciMEMurat Eravci
- Chrisostomos ProdromouChrisostomos Prodromou
- Erika J. ManciniEMErika J. Mancini
Open Access
Abstract
Lemur tail kinase 3 (LMTK3) is an oncogenic Ser/Thr kinase implicated in breast cancer (BC) progression, therapy resistance, and poor clinical outcomes, yet the molecular mechanisms governing its regulation remain poorly understood, particularly the role of its C-terminal intrinsically disordered region (IDR). Given that IDRs frequently harbour hidden structural motifs that control protein dynamics, we combined computational, biophysical, and biochemical approaches to systematically map regulatory elements within the LMTK3 C-terminus, identifying two regions (residues 688–1095 and 1181–1486) that interact with the LMTK3 kinase domain (LMTK3-KD). Characterisation of these interactions revealed that LMTK31181–1486 displays preferential binding to inactive wild-type LMTK3-KD over a constitutively active mutant (LMTK3-KDL313R), a behaviour consistent with a potential autoinhibitory interaction. Guided by AlphaFold3 modelling, we localised this interaction primarily to a short α-helical motif (α-helix 2; residues 1247–1258) within the C-terminal IDR and subsequently identified Ser1258 within this motif as a candidate regulatory phosphorylation site, using [γ-32P]-ATP kinase assays and mass spectrometry. Phosphorylation at Ser1258 altered interactions between α-helix 2 and the kinase domain, reducing binding to wild-type LMTK3-KD while increasing affinity for LMTK3-KDL313R. Functionally, phospho-null mutation of Ser1258 impaired oestrogen receptor alpha (ERα) upregulation, proliferation, migration, and clonogenicity in ER-positive BC cell lines, and reduced tumour growth in female BALB/c nude mice bearing orthotopic MCF7 xenografts. Together, these findings identify a previously uncharacterised regulatory element within the LMTK3 C-terminus and support a model in which Ser1258 phosphorylation modulates kinase domain interactions and LMTK3-driven oncogenic functions in BC.Keywords
Funding Information
- University of Sussex
- Action Against Cancer (6292/G1828)
This publication has 103 references indexed in Scilit:
- The LMTK-family of kinases: Emerging important players in cell physiology and pathogenesisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2021
- Microscale Thermophoresis (MST) to Detect the Interaction Between Purified Protein and Small Molecule2020
- LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathwayFEBS Open Bio, 2020
- The Ys and wherefores of protein kinase autoinhibitionBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2015
- Preoperative serum LMTK3 as a novel biomarker in non-small cell lung cancerTumor Biology, 2014
- Structure and evolutionary origins of the CMG complexChromosoma, 2013
- The GINS Complex: Structure and Function2012
- LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcomeBreast Cancer Research and Treatment, 2011
- Serine/Threonine Protein Kinases and ApoptosisExperimental Cell Research, 2000
- Serine Phosphorylation of Syndecan-2 Proteoglycan Cytoplasmic DomainArchives of Biochemistry and Biophysics, 1997